Breadcrumb Home IMPAACT News IMPAACT News News July 2024 Meetings Register for the 2024 IMPAACT Annual Meeting July 2024 Spotlight Series Social Behavioral Scientific Core (SBSC) Spotlight Series: August 2024 July 2024 Announcements European Medicines Agency Approves Triumeq PD® for Infants and Young Children Based on IMPAACT Data Search Enter a search term. Filter Topics AllAnnouncementsMeetingsSpotlight SeriesStudy Results Date All202420232022202120202019201820162014 Sort Date AscDate Desc Submit Search Showing 88 news items. October 2022 Announcements The NIH/DAIDS Cross-Network (ACTG/HVTN/IMPAACT) TB Working Group calls for people living with HIV to be included in tuberculosis vaccine development. September 2022 Spotlight Series Social Behavioral Scientific Core (SBSC) Spotlight Series: September 2022 August 2022 Spotlight Series Social Behavioral Scientific Core (SBSC) Spotlight Series: October 2022 July 2022 Meetings IMPAACT at International Workshop on HIV Pediatrics 2022 and AIDS 2022 July 2022 Announcements JIAS Special Issue: ‘Approaches to enhance and accelerate investigation of new HIV drugs in pregnancy’ April 2022 Announcements The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network is delighted to announce the publication of results from IMPAACT P1093 in the May 2022 edition of The Lancet HIV. March 2022 Announcements IMPAACT 2017 (MOCHA) Data Informs U.S. FDA Approval of Cabenuva for HIV Treatment in Virologically Suppressed Adolescents March 2022 Announcements IMPAACT 2014 Informs U.S. FDA’s Approval for Use of Doravirine in Pifeltro® and Delstrigo® Among Children February 2022 Study Results IMPAACT Shares Study Results in CROI 2022 Oral Presentations February 2022 Study Results IMPAACT P1107 Team Presents First Known Case of a Woman with HIV Remission Pagination Previous page Prev Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 Next page Next
July 2024 Announcements European Medicines Agency Approves Triumeq PD® for Infants and Young Children Based on IMPAACT Data
October 2022 Announcements The NIH/DAIDS Cross-Network (ACTG/HVTN/IMPAACT) TB Working Group calls for people living with HIV to be included in tuberculosis vaccine development.
September 2022 Spotlight Series Social Behavioral Scientific Core (SBSC) Spotlight Series: September 2022
July 2022 Announcements JIAS Special Issue: ‘Approaches to enhance and accelerate investigation of new HIV drugs in pregnancy’
April 2022 Announcements The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network is delighted to announce the publication of results from IMPAACT P1093 in the May 2022 edition of The Lancet HIV.
March 2022 Announcements IMPAACT 2017 (MOCHA) Data Informs U.S. FDA Approval of Cabenuva for HIV Treatment in Virologically Suppressed Adolescents
March 2022 Announcements IMPAACT 2014 Informs U.S. FDA’s Approval for Use of Doravirine in Pifeltro® and Delstrigo® Among Children
February 2022 Study Results IMPAACT P1107 Team Presents First Known Case of a Woman with HIV Remission